{"count": 9, "results": [{"_id": "40003624", "pmid": 40003624, "title": "Drug-Induced Complete Atrioventricular Block in an Elderly Patient: A Case Report Highlighting Digoxin-Beta Blocker Interactions and a Paradoxical State.", "journal": "Life (Basel)", "authors": ["Bustea C", "Radu AF", "Vesa CM", "Radu A", "Bodog TM", "Bodog RF", "Maghiar PB", "Maghiar AM"], "date": "2025-01-31T00:00:00Z", "doi": "10.3390/life15020215", "meta_date_publication": "2025 Jan 31", "meta_volume": "15", "meta_issue": "2", "meta_pages": "", "score": 50238.25, "text_hl": "Her medical history included @<m>DISEASE_Atrial_Fibrillation</m> @DISEASE_MESH:D001281 @@@atrial fibrillation@@@, @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@, and @DISEASE_Heart_Failure @DISEASE_MESH:D006333 @@@heart failure@@@, with a medication regimen of @CHEMICAL_Digoxin @CHEMICAL_MESH:D004077 @@@digoxin@@@ 0.25 mg given daily 5 days out of 7, @CHEMICAL_Metoprolol @CHEMICAL_MESH:D008790 @@@metoprolol@@@ 50 mg twice daily, @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ 10 mg daily, @CHEMICAL_Furosemide @CHEMICAL_MESH:D005665 @@@furosemide@@@ 40 mg daily, and @CHEMICAL_Spironolactone @CHEMICAL_MESH:D013148 @@@spironolactone@@@ 50 mg daily. ", "citations": {"NLM": "Bustea C, Radu AF, Vesa CM, Radu A, Bodog TM, Bodog RF, Maghiar PB, Maghiar AM. Drug-Induced Complete Atrioventricular Block in an Elderly Patient: A Case Report Highlighting Digoxin-Beta Blocker Interactions and a Paradoxical State. Life (Basel). 2025 Jan 31;15(2):. PMID: 40003624", "BibTeX": "@article{40003624, title={Drug-Induced Complete Atrioventricular Block in an Elderly Patient: A Case Report Highlighting Digoxin-Beta Blocker Interactions and a Paradoxical State.}, author={Bustea C and Radu AF and Vesa CM and Radu A and Bodog TM and Bodog RF and Maghiar PB and Maghiar AM}, journal={Life (Basel)}, volume={15}, number={2}}"}}, {"_id": "12836710", "pmid": 12836710, "title": "Effects of lisinopril in patients with heart failure and chronic atrial fibrillation.", "journal": "J Card Fail", "authors": ["Van Den Berg MP", "Crijns HJ", "Van Veldhuisen DJ", "Griep N", "De Kam PJ", "Lie KI"], "date": "1995-12-01T00:00:00Z", "doi": "10.1016/s1071-9164(05)80004-1", "meta_date_publication": "1995 Dec", "meta_volume": "1", "meta_issue": "5", "meta_pages": "355-63", "score": 50072.527, "text_hl": "Effects of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ in @SPECIES_9606 @@@patients@@@ with @DISEASE_Heart_Failure @DISEASE_MESH:D006333 @@@heart failure@@@ and chronic @<m>DISEASE_Atrial_Fibrillation</m> @DISEASE_MESH:D001281 @@@atrial fibrillation@@@.", "citations": {"NLM": "Van Den Berg MP, Crijns HJ, Van Veldhuisen DJ, Griep N, De Kam PJ, Lie KI. Effects of lisinopril in patients with heart failure and chronic atrial fibrillation. J Card Fail. 1995 Dec;1(5):355-63. PMID: 12836710", "BibTeX": "@article{12836710, title={Effects of lisinopril in patients with heart failure and chronic atrial fibrillation.}, author={Van Den Berg MP and Crijns HJ and Van Veldhuisen DJ and Griep N and De Kam PJ and Lie KI}, journal={J Card Fail}, volume={1}, number={5}, pages={355-63}}"}}, {"_id": "29212812", "pmid": 29212812, "title": "Pharmacologic Prevention of Incident Atrial Fibrillation: Long-Term Results From the ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).", "journal": "Circ Arrhythm Electrophysiol", "authors": ["Dewland TA", "Soliman EZ", "Yamal JM", "Davis BR", "Alonso A", "Albert CM", "Simpson LM", "Haywood LJ", "Marcus GM"], "date": "2017-12-01T00:00:00Z", "doi": "10.1161/CIRCEP.117.005463", "meta_date_publication": "2017 Dec", "meta_volume": "10", "meta_issue": "12", "meta_pages": "", "score": 50058.875, "text_hl": "We sought to determine whether randomization to @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ reduces incident @<m>DISEASE_Atrial_Fibrillation</m> @DISEASE_MESH:D001281 @@@AF@@@ or @DISEASE_Atrial_Flutter @DISEASE_MESH:D001282 @@@atrial flutter@@@ (@DISEASE_Atrial_Flutter @DISEASE_MESH:D001282 @@@AFL@@@) compared with @CHEMICAL_Chlorthalidone @CHEMICAL_MESH:D002752 @@@chlorthalidone@@@ in a large clinical trial cohort with extended post-trial surveillance. ", "citations": {"NLM": "Dewland TA, Soliman EZ, Yamal JM, Davis BR, Alonso A, Albert CM, Simpson LM, Haywood LJ, Marcus GM. Pharmacologic Prevention of Incident Atrial Fibrillation: Long-Term Results From the ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial). Circ Arrhythm Electrophysiol. 2017 Dec;10(12):. PMID: 29212812", "BibTeX": "@article{29212812, title={Pharmacologic Prevention of Incident Atrial Fibrillation: Long-Term Results From the ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).}, author={Dewland TA and Soliman EZ and Yamal JM and Davis BR and Alonso A and Albert CM and Simpson LM and Haywood LJ and Marcus GM}, journal={Circ Arrhythm Electrophysiol}, volume={10}, number={12}}"}}, {"_id": "20017344", "pmid": 20017344, "title": "[Preventive strategy for atrial fibrillation in arterial hypertension].", "journal": "Klin Med (Mosk)", "authors": ["Akhmedov VA", "Dolgikh VT", "Naumov DV", "Dvornikov VE"], "date": "2009-01-01T00:00:00Z", "meta_date_publication": "2009", "meta_volume": "87", "meta_issue": "10", "meta_pages": "17-9", "score": 50057.07, "text_hl": "[Preventive strategy for @<m>DISEASE_Atrial_Fibrillation</m> @DISEASE_MESH:D001281 @@@atrial fibrillation@@@ in @DISEASE_Pulmonary_Arterial_Hypertension @DISEASE_MESH:D000081029 @@@arterial hypertension@@@].", "citations": {"NLM": "Akhmedov VA, Dolgikh VT, Naumov DV, Dvornikov VE. [Preventive strategy for atrial fibrillation in arterial hypertension]. Klin Med (Mosk). 2009;87(10):17-9. PMID: 20017344", "BibTeX": "@article{20017344, title={[Preventive strategy for atrial fibrillation in arterial hypertension].}, author={Akhmedov VA and Dolgikh VT and Naumov DV and Dvornikov VE}, journal={Klin Med (Mosk)}, volume={87}, number={10}, pages={17-9}}"}}, {"_id": "9179087", "pmid": 9179087, "title": "Effect of angiotensin-converting enzyme inhibitor therapy in mitral regurgitation with normal left ventricular function.", "journal": "Can J Cardiol", "authors": ["Marcotte F", "Honos GN", "Walling AD", "Beauvais D", "Blais MJ", "Daoust C", "Lisbona A", "McCans JL"], "date": "1997-05-01T00:00:00Z", "meta_date_publication": "1997 May", "meta_volume": "13", "meta_issue": "5", "meta_pages": "479-85", "score": 50048.99, "text_hl": "The study drug was stopped in four @SPECIES_9606 @@@patients@@@ after one @SPECIES_9606 @@@patient@@@ presented with rapid @<m>DISEASE_Atrial_Fibrillation</m> @DISEASE_MESH:D001281 @@@atrial fibrillation@@@ and @DISEASE_Angina_Pectoris @DISEASE_MESH:D000787 @@@angina@@@ while three @SPECIES_9606 @@@patients@@@ were intolerant to @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@. ", "citations": {"NLM": "Marcotte F, Honos GN, Walling AD, Beauvais D, Blais MJ, Daoust C, Lisbona A, McCans JL. Effect of angiotensin-converting enzyme inhibitor therapy in mitral regurgitation with normal left ventricular function. Can J Cardiol. 1997 May;13(5):479-85. PMID: 9179087", "BibTeX": "@article{9179087, title={Effect of angiotensin-converting enzyme inhibitor therapy in mitral regurgitation with normal left ventricular function.}, author={Marcotte F and Honos GN and Walling AD and Beauvais D and Blais MJ and Daoust C and Lisbona A and McCans JL}, journal={Can J Cardiol}, volume={13}, number={5}, pages={479-85}}"}}, {"_id": "24794785", "pmid": 24794785, "title": "Prolonged anticoagulant activity of rivaroxaban in a polymorbid elderly female with non-convulsive epileptic state.", "journal": "Heart Lung", "authors": ["Stöllberger C", "Finsterer J"], "date": "2014-05-01T00:00:00Z", "doi": "10.1016/j.hrtlng.2014.03.004", "meta_date_publication": "2014 May-Jun", "meta_volume": "43", "meta_issue": "3", "meta_pages": "262-3", "score": 50044.184, "text_hl": "CASE REPORT: A 88-years-old female (body-mass-index = 19.95) with @<m>DISEASE_Atrial_Fibrillation</m> @DISEASE_MESH:D001281 @@@AF@@@, @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ and @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes mellitus@@@, hospitalized because of @DISEASE_Heart_Failure @DISEASE_MESH:D006333 @@@heart failure@@@ and a non-@DISEASE_Seizures @DISEASE_MESH:D012640 @@@convulsive epileptic@@@ state, was treated by @CHEMICAL_Valproic_Acid @CHEMICAL_MESH:D014635 @@@valproate@@@, mirtazepin, @CHEMICAL_Nebivolol @CHEMICAL_MESH:D000068577 @@@nebivolol@@@, @CHEMICAL_Digitoxin @CHEMICAL_MESH:D004074 @@@digitoxin@@@, @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@, @CHEMICAL_Gliclazide @CHEMICAL_MESH:D005907 @@@gliclazide@@@ and @CHEMICAL_Amlodipine @CHEMICAL_MESH:D017311 @@@amlodipine@@@. ", "citations": {"NLM": "Stöllberger C, Finsterer J. Prolonged anticoagulant activity of rivaroxaban in a polymorbid elderly female with non-convulsive epileptic state. Heart Lung. 2014 May-Jun;43(3):262-3. PMID: 24794785", "BibTeX": "@article{24794785, title={Prolonged anticoagulant activity of rivaroxaban in a polymorbid elderly female with non-convulsive epileptic state.}, author={Stöllberger C and Finsterer J}, journal={Heart Lung}, volume={43}, number={3}, pages={262-3}}"}}, {"_id": "23550397", "pmid": 23550397, "title": "ECG of the month. Irregular rhythm in a 25-year-old man with three prior cardiac operations. Coarse atrial fibrillation with a rapid ventricular response, left anterior fascicular block, left ventricular hypertrophy with repolarization abnormality.", "journal": "J La State Med Soc", "authors": ["Glancy DL", "Ahmed J", "Ayalloore SG", "LeLorier PA", "Diwan PM", "Helmcke FR"], "date": "2013-01-01T00:00:00Z", "meta_date_publication": "2013 Jan-Feb", "meta_volume": "165", "meta_issue": "1", "meta_pages": "40-1", "score": 50041.668, "text_hl": "@DISEASE_Menstruation_Disturbances @DISEASE_MESH:D008599 @@@Irregular rhythm@@@ in a 25-year-old man with three prior cardiac operations. Coarse @<m>DISEASE_Atrial_Fibrillation</m> @DISEASE_MESH:D001281 @@@atrial fibrillation@@@ with a rapid ventricular response, @DISEASE_Bundle_Branch_Block @DISEASE_MESH:D002037 @@@left anterior fascicular block@@@, @DISEASE_Hypertrophy_Left_Ventricular @DISEASE_MESH:D017379 @@@left ventricular hypertrophy@@@ with repolarization abnormality.", "citations": {"NLM": "Glancy DL, Ahmed J, Ayalloore SG, LeLorier PA, Diwan PM, Helmcke FR. ECG of the month. Irregular rhythm in a 25-year-old man with three prior cardiac operations. Coarse atrial fibrillation with a rapid ventricular response, left anterior fascicular block, left ventricular hypertrophy with repolarization abnormality. J La State Med Soc. 2013 Jan-Feb;165(1):40-1. PMID: 23550397", "BibTeX": "@article{23550397, title={ECG of the month. Irregular rhythm in a 25-year-old man with three prior cardiac operations. Coarse atrial fibrillation with a rapid ventricular response, left anterior fascicular block, left ventricular hypertrophy with repolarization abnormality.}, author={Glancy DL and Ahmed J and Ayalloore SG and LeLorier PA and Diwan PM and Helmcke FR}, journal={J La State Med Soc}, volume={165}, number={1}, pages={40-1}}"}}, {"_id": "12835154", "pmid": 12835154, "title": "Ask the doctor. I am 75 and have had atrial fibrillation for a while. I take digoxin, lisinopril, Coumadin, and Lipitor. My medications seem to work, but I'm still concerned about the big difference between my systolic and diastolic blood pressure readings. The systolic is usually between 130 and 150 and the diastolic is between 55 and 70. Should I worry about this?", "journal": "Harv Heart Lett", "date": "2003-06-01T00:00:00Z", "meta_date_publication": "2003 Jun", "meta_volume": "13", "meta_issue": "10", "meta_pages": "8", "score": 50041.168, "text_hl": "I am 75 and have had @<m>DISEASE_Atrial_Fibrillation</m> @DISEASE_MESH:D001281 @@@atrial fibrillation@@@ for a while. ", "citations": {"NLM": "Ask the doctor. I am 75 and have had atrial fibrillation for a while. I take digoxin, lisinopril, Coumadin, and Lipitor. My medications seem to work, but I'm still concerned about the big difference between my systolic and diastolic blood pressure readings. The systolic is usually between 130 and 150 and the diastolic is between 55 and 70. Should I worry about this? Harv Heart Lett. 2003 Jun;13(10):8. PMID: 12835154", "BibTeX": "@article{12835154, title={Ask the doctor. I am 75 and have had atrial fibrillation for a while. I take digoxin, lisinopril, Coumadin, and Lipitor. My medications seem to work, but I'm still concerned about the big difference between my systolic and diastolic blood pressure readings. The systolic is usually between 130 and 150 and the diastolic is between 55 and 70. Should I worry about this?}, journal={Harv Heart Lett}, volume={13}, number={10}, pages={8}}"}}, {"_id": "33457061", "pmid": 33457061, "pmcid": "PMC7779571", "title": "Therapy Management Using Modified 2-Weeks-On/1-Week-Off Dosing Schedule in Patients With Metastatic Renal Cell Carcinoma Receiving Sunitinib: A Hypothetical, Illustrative Case Scenario", "journal": "J Adv Pract Oncol", "authors": ["Allman KD", "Ryan JC", "Clair A", "Yenser-Wood S"], "date": "2019-07-01T00:00:00Z", "doi": "10.6004/jadpro.2019.10.5.6", "meta_date_publication": "2019 Jul", "meta_volume": "10", "meta_issue": "5", "meta_pages": "483-493", "score": 50020.2, "text_hl": "Brady's medical history includes nonvalvular @<m>DISEASE_Atrial_Fibrillation</m> @DISEASE_MESH:D001281 @@@atrial fibrillation@@@, which is treated with @CHEMICAL_apixaban @CHEMICAL_MESH:C522181 @@@apixaban@@@; @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ that is adequately controlled (blood pressure 137/79 mm Hg) with @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ at 20 mg/day; @DISEASE_Coronary_Artery_Disease @DISEASE_MESH:D003324 @@@coronary artery disease@@@; and @DISEASE_Hyperlipidemias @DISEASE_MESH:D006949 @@@hyperlipidemia@@@ that is treated with @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@ at 20 mg/day. ", "citations": {"NLM": "Allman KD, Ryan JC, Clair A, Yenser-Wood S. Therapy Management Using Modified 2-Weeks-On/1-Week-Off Dosing Schedule in Patients With Metastatic Renal Cell Carcinoma Receiving Sunitinib: A Hypothetical, Illustrative Case Scenario J Adv Pract Oncol. 2019 Jul;10(5):483-493. PMID: 33457061", "BibTeX": "@article{33457061, title={Therapy Management Using Modified 2-Weeks-On/1-Week-Off Dosing Schedule in Patients With Metastatic Renal Cell Carcinoma Receiving Sunitinib: A Hypothetical, Illustrative Case Scenario}, author={Allman KD and Ryan JC and Clair A and Yenser-Wood S}, journal={J Adv Pract Oncol}, volume={10}, number={5}, pages={483-493}}"}}]}